NASDAQ: CVKD
Cadrenal Therapeutics Inc Stock Ownership - Who owns Cadrenal Therapeutics?

Insider buying vs selling

Have Cadrenal Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Quang X. PhamChairman and CEO2026-06-297,400$3.03
$22.42kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-269,029$3.05
$27.54kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-252,127$3.00
$6.38kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-232,277$3.20
$7.29kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-229,167$3.55
$32.54kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-17513$3.16
$1.62kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-163,613$3.18
$11.49kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-153,666$3.58
$13.12kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-1212,996$3.94
$51.20kSell
Quang X. PhamChairman CEO and Interim CFO2026-06-111,462$4.12
$6.02kSell

1 of 3

CVKD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CVKD insiders and whales buy or sell their stock.

CVKD Shareholders

What type of owners hold Cadrenal Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
John Raymond Murphy17.23%614,792$582.82kInsider
Quang X. Pham8.37%298,589$283.06kInsider
Glynn Wilson1.40%50,000$47.40kInsider
Steven Zelenkofske1.12%40,000$37.92kInsider
Lee Scott Golden0.05%1,667$1.58kInsider
Vangrd0.00%50$47.40Institution
Vanguard Capital Management LLC0.00%50$47.40Institution
Hrt Financial LP0.00%29$27.49Institution
Hrtfin0.00%29$27.49Institution
Geodec0.00%19$18.01Institution

1 of 5

CVKD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CVKD0.00%28.17%Net Selling
DRMA0.00%100.00%Net Buying
SXTP0.01%99.99%Net Buying
GRI0.00%100.00%
ERNA0.00%100.00%Net Buying

Cadrenal Therapeutics Stock Ownership FAQ

Who owns Cadrenal Therapeutics?

Cadrenal Therapeutics (NASDAQ: CVKD) is owned by 0.00% institutional shareholders, 28.17% Cadrenal Therapeutics insiders, and 71.83% retail investors. John Raymond Murphy is the largest individual Cadrenal Therapeutics shareholder, owning 614,792.00 shares representing 17.23% of the company. John Raymond Murphy's Cadrenal Therapeutics shares are currently valued at $579.75k.

If you're new to stock investing, here's how to buy Cadrenal Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.